全文获取类型
收费全文 | 69074篇 |
免费 | 6388篇 |
国内免费 | 5046篇 |
专业分类
耳鼻咽喉 | 400篇 |
儿科学 | 719篇 |
妇产科学 | 876篇 |
基础医学 | 8697篇 |
口腔科学 | 1185篇 |
临床医学 | 9269篇 |
内科学 | 10545篇 |
皮肤病学 | 766篇 |
神经病学 | 3645篇 |
特种医学 | 2409篇 |
外国民族医学 | 41篇 |
外科学 | 7068篇 |
综合类 | 11937篇 |
现状与发展 | 17篇 |
一般理论 | 2篇 |
预防医学 | 4255篇 |
眼科学 | 1824篇 |
药学 | 7348篇 |
74篇 | |
中国医学 | 3660篇 |
肿瘤学 | 5771篇 |
出版年
2024年 | 223篇 |
2023年 | 1193篇 |
2022年 | 2841篇 |
2021年 | 3570篇 |
2020年 | 2597篇 |
2019年 | 2357篇 |
2018年 | 2382篇 |
2017年 | 2045篇 |
2016年 | 2052篇 |
2015年 | 3131篇 |
2014年 | 3935篇 |
2013年 | 3262篇 |
2012年 | 4783篇 |
2011年 | 5662篇 |
2010年 | 3269篇 |
2009年 | 2478篇 |
2008年 | 3430篇 |
2007年 | 3514篇 |
2006年 | 3603篇 |
2005年 | 3443篇 |
2004年 | 2232篇 |
2003年 | 2194篇 |
2002年 | 1830篇 |
2001年 | 1685篇 |
2000年 | 1768篇 |
1999年 | 1965篇 |
1998年 | 1251篇 |
1997年 | 1342篇 |
1996年 | 1007篇 |
1995年 | 888篇 |
1994年 | 768篇 |
1993年 | 488篇 |
1992年 | 602篇 |
1991年 | 520篇 |
1990年 | 446篇 |
1989年 | 393篇 |
1988年 | 324篇 |
1987年 | 283篇 |
1986年 | 249篇 |
1985年 | 173篇 |
1984年 | 102篇 |
1983年 | 71篇 |
1982年 | 38篇 |
1981年 | 52篇 |
1980年 | 28篇 |
1979年 | 38篇 |
1963年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
Xiaoguang Zhu Raymond Q Migrino Robert S Hellman Tejas Brahmbhatt Ming Zhao 《Nuclear medicine communications》2008,29(9):764-769
OBJECTIVE: The C2A domain of Synaptotagmin I is a molecular probe for the specific imaging of cell death. Here we test the hypothesis that the uptake of 99mTc-C2A in the acute phase of an infarction is associated with cardiac dysfunction in follow-ups. METHODS: The left coronary artery was occluded in Sprague-Dawley rats for 0, 10, 20, and 30 min. 99mTc-C2A was injected intravenously at 2 h of reperfusion. Anterior planar images were acquired with one million counts on a gamma camera 3 h after injection. 99mTc-C2A uptake was calculated as the total counts in the left ventricle region minus blood pool signal. The in-vivo signal detected was correlated with wall motion score index at 1 and 3 weeks follow-ups measured by echocardiography. RESULTS: 99mTc-C2A uptake was higher with increased ischemic time (2244+/-852, 4054+/-1223, and 6178+/-1451 for 10, 20, and 30 min ischemia, analysis of variance P<0.001). A significant correlation was found between 99mTc-C2A uptake and wall motion score index at 1 week (R=0.800, P=0.0006) and 3 weeks (R=0.810, P=0.0008). CONCLUSION: In this ischemia/reperfusion model, 99mTc-C2A uptake in the acute phase was associated with functional abnormality at 1 and 3 weeks. This demonstrates the potential diagnostic and prognostic value of 99mTc-C2A as a novel imaging agent. 相似文献
72.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
73.
Ke-Xiang Liu Fumio Yamamoto Hiroshi Yamamoto Tiance Wang Zhicheng Zhu Rihao Xu Shudong Zhang 《Annals of thoracic and cardiovascular surgery》2007,13(5):301-307
OBJECTIVES: We investigated whether the Na+-H+ exchange inhibitor, HOE642 (Hoe), and/or the Na channel blocker, mexiletine (Mex), enhance a cardioprotective effect on St. Thomas' Hospital cardioplegic solution (STS) to clarify the mechanism by which intracellular Na+ is accumulated after cardioplegic arrest. MATERIALS AND METHODS: Isolated working rat hearts were perfused with Krebs-Henseleit bicarbonate buffer (KHBB). The hearts were then arrested with STS and subjected to normothermic global ischemia (30 min). This was followed by Langendorff reperfusion (15 min) and then a working reperfusion (20 min). In study A, we added Hoe (5, 10, and 20 microM), Mex (70 microM), or a combination of Hoe (20 microM) and Mex (70 microM), to STS. In study B, we added Hoe (20 microM), Mex (70 microM), or a combination of Hoe (20 microM) and Mex (70 microM) to KHBB during the first 3 min of Langendorff reperfusion. RESULTS: In study A, the addition of Hoe (10 and 20 microM) to STS showed a significantly greater postischemic recovery of cardiac output compared to the control group [63.1+/-5.7% (10 microM), 62.7+/-4.7% (20 microM), and 55.5+/-4.6% (control), respectively]. The postischemic recovery of cardiac output was significantly greater in the group of the combined addition (Hoe and Mex) to STS than that in the control, 20 microM Hoe, 70 microM Mex groups [70.3+/-3.7 (Hoe and Mex), 55.5+/-4.6% (control), 62.7+/-4.7% (Hoe 20 microM), and 60.2+/-4.7% (Mex 70 microM), respectively]. The myocardial water content in the postischemic period was 565.1+/-29.1, 525.8+/-2.9, 509.4+/-19.6, and 532.2+/-20.1; it was 497.3+/-9.1 mL/100 g dry weight in the control; and 10 microM Hoe, 20 microM Hoe, and 70 microM Mex in the combined use groups. In study B, there was no significant difference in the postischemic recovery of cardiac output in all experimental groups. CONCLUSION: The combined use of the Na+-H+ exchange inhibitor and Na+ channel blocker during cardioplegia may achieve a superior cardioprotective effect on myocardial damage because of ischemia and reperfusion. 相似文献
74.
川芎嗪对肾缺血再灌注时c-fos bcl-2 ICAM-1蛋白表达的影响 总被引:1,自引:0,他引:1
目的 探讨大鼠肾缺血再灌注损伤不同时间c -fos、细胞淋巴瘤 /白血病 - 2、细胞间粘附分子- 1蛋白的表达及川芎嗪对其影响。方法 用免疫组化法检测大鼠急性肾缺血再灌注不同时间内及川芎嗪干预后c -fos、细胞淋巴瘤 /白血病 - 2、细胞间粘附分子 - 1蛋白表达的分布及强度变化。结果 c -fos蛋白分布于近曲小管、远曲小管、集合管上皮细胞的细胞核、细胞浆内 ,再灌注后 1h表达明显增强 ,3h达高峰 ,6h锐减。细胞淋巴瘤 /白血病 - 2蛋白主要分布于近曲小管上皮细胞的细胞浆 ,再灌注后 1h表达明显增强 ,6h达高峰 ,2 4h仍有较强表达。细胞间粘附分子 - 1蛋白分布在肾血管、肾小管等部位 ,其中以肾血管为著 ,其表达增强于再灌注后 1h ,直到 2 4h仍有增高趋势。川芎嗪干预后c -fos、细胞间粘附分子 - 1蛋白表达明显下降 (P <0 0 1 )。细胞淋巴瘤 /白血病 - 2表达明显增高 (P <0 .0 1 )。结论 川芎嗪对肾缺血再灌注损伤有较好的保护作用 相似文献
75.
目的 探讨血管新生指标CD34、CD31、vWF、Ⅳ型胶原纤维及层粘连蛋白在肝细胞肝癌(HCC)中的表达及意义 ,同时比较上述几种血管新生因子与增殖细胞核抗原 (PCNA)、病理指标及预后的相关性 ,以便筛选出有效的临床预后指标。方法 采用免疫组化方法 ,对 5 3例肝细胞肝癌的标本进行CD31、CD34、vWF、Ⅳ型胶原纤维及层粘连蛋白的染色、计数 ,并用检测数据与患者的临床资料进行统计分析。结果 统计染色的血管面积后发现 ,CD34与多种临床病理指标无相关性 ;CD31与肝内门静脉浸润相关 ;vWF与肿瘤的TNM分期及肝内门静脉浸润呈正相关 ;CollⅣ与肝内门静脉浸润呈正相关、与术后生存期呈负相关 ;Lam与肝硬化及术中出血量呈负相关、与术后生存期呈正相关。PCNA与肿瘤TNM分期有关。结论 在HCC中 ,CollⅣ、vWF、及CD31为肝细胞肝癌的有效血管新生及预后指标 ;Lam则与肝硬化及术中出血相关 ;PCNA指数肿瘤分期有关 ;CD34不能用作血管新生或预后指标 相似文献
76.
目的总结等长收缩运动治疗单纯颈伸肌劳损的疗效。方法随机将56例单纯颈伸肌劳损分为两组,一组应用等长收缩运动进行治疗,另一组应用手法治疗,对比两组患者疗效。结果治疗1周后,两组患者的总有效率均为100%(P〉0.05)。结论等长收缩运动治疗单纯颈伸肌劳损的疗效与手法治疗相近,但该法具有更安全、经济、且不受条件、时间限制,更有主动巩固疗效和积极预防的作用。 相似文献
77.
78.
目的 了解目前国内中药治疗绝经后骨质疏松症的临床治疗研究的现状。方法 对检索到的50篇有关中药治疗绝经后骨质疏松症的临床研究论文,按照牛津循证医学中心证据水平标准和临床试验的没计原则,从诊断标准、纳入和排除标准、组间基线可比性、随机、对照、双盲、统计学方法、疗效判断、疗程及药物的不良反应、随访等多个方面进行分析评价。结果 50篇相关文献中,按照牛津循证医学中心证据水平标准评价,推荐级别为B级的占44.0%,C级的占56.0%;证据水平为2b级的占40.0%,3b级的占4.0%,4级的占56.0%;随机对照试验文献占44.0%;临床对照试验文献占4.0%;采用随机双盲者占9.1%,随机单盲者占18.2%,说明组间基线可比的占31.8%,有诊断标准的占90.9%,有纳入和排除标准的占86.4%,说明统计方法的占52.4%,有客观疗效评价指标的占90.9%,说明药物不良反应的占9.1%。结论 有关中医药治疗绝经后骨质疏松症的临床研究论文日益增多,但随机对照试验比例偏低,研究设计及论文撰写水平有待进一步提高。 相似文献
79.
老年新鲜股骨颈骨折治疗方法探讨 总被引:1,自引:0,他引:1
目的 探讨老年新鲜股骨颈骨折的术式选择。方法 回顾性分析217例60岁以上新鲜股骨颈骨折,分别采用单钉固定(46例)、多针固定(37例)、AO空心钉固定(79例)、人工髋关节置换(55例)4种方法,对比骨折愈合率、股骨头坏死率、髋关节功能恢复优良率。结果 内固定组骨折愈合率83.3%(140/162),股骨头坏死率19.1%(31/162),髋关节功能优良率75.9%(123/162)。其中空心钉组骨折愈合率94.9%(75/79),股骨头坏死率6.3%(5/79),髋关节功能优良率91.1%(72/79)。人工关节组髋关节功能优良率89.1%(49/55)。结论 内固定手术对老年新鲜股骨颈骨折有意义,AO空心钉固定操作简单,骨折愈合率高,可作首选内固定。人工髋关节置换应严格掌握适应证。 相似文献
80.